{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:21:17Z","timestamp":1784809277371,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T00:00:00Z","timestamp":1621728000000},"content-version":"vor","delay-in-days":142,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.lrr.2021.100252","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T12:10:11Z","timestamp":1621858211000},"page":"100252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study"],"prefix":"10.1016","volume":"15","author":[{"given":"Fadi","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Al","family":"Ghoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saada","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Ammanouil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Riachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souheil","family":"Hallit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2021.100252_bib0001","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02983377","article-title":"Survival and proliferation factors of normal and malignant plasma cells","volume":"78","author":"Klein","year":"2003","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.lrr.2021.100252_bib0002","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lrr.2021.100252_bib0003","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study","volume":"4","author":"Cowan","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.lrr.2021.100252_bib0004","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3816\/CLML.2010.n.080","article-title":"Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma","volume":"10","author":"Talamo","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.lrr.2021.100252_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2018.12.001","article-title":"Laboratory assessment of multiple myeloma","volume":"89","author":"Morrison","year":"2019","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.lrr.2021.100252_bib0006","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lrr.2021.100252_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-019-0205-9","article-title":"Current status of autologous stem cell transplantation for multiple myeloma","volume":"9","author":"Hamed","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.lrr.2021.100252_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14196\/mjiri.32.1","article-title":"Characteristics and outcomes of patients with multiple myeloma\u00a0: Data from a developing country","volume":"32","author":"Hameed","year":"2018","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.lrr.2021.100252_bib0009","first-page":"376","article-title":"FACTORS AFFECTING OUTCOME OF PATIENTS WITH MULTIPLE MYELOMA","volume":"26","author":"Basit","year":"2014","journal-title":"Journal of Ayub Medical College Abbottabad"},{"key":"10.1016\/j.lrr.2021.100252_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome","volume":"335","author":"Attal","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lrr.2021.100252_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.lrr.2021.100252_bib0012","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ajh.25117","article-title":"Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management","volume":"93","author":"Rajkumar","year":"2018","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.lrr.2021.100252_bib0013","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-319-40320-5_9","article-title":"Management of Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma","volume":"169","author":"Laubach","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.lrr.2021.100252_bib0014","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S1470-2045(15)00389-7","article-title":"Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial","volume":"16","author":"Gay","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lrr.2021.100252_bib0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1402888","article-title":"Autologous Transplantation and Maintenance Therapy in Multiple Myeloma","volume":"371","author":"Palumbo","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.lrr.2021.100252_bib0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma","volume":"335","author":"Attal","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.lrr.2021.100252_bib0017","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma","volume":"376","author":"Attal","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.lrr.2021.100252_bib0018","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00277-018-3370-1","article-title":"Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma","volume":"97","author":"Aggarwal","year":"2018","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.lrr.2021.100252_bib0019","unstructured":"Durie-Salmon Staging System. International Myeloma Foundation https:\/\/www.myeloma.org\/durie-salmon-staging."},{"key":"10.1016\/j.lrr.2021.100252_bib0020","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.5083.5083","article-title":"Frequency and Prognostic Significance of Hypercalcemia in Patients with Multiple Myeloma: An Analysis of the Database of the Greek Myeloma Study Group","volume":"118","author":"Kastritis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2021.100252_bib0021","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/ejh.12923","article-title":"Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies","volume":"99","author":"Zagouri","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.lrr.2021.100252_bib0022","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-0609.2000.90221.x","article-title":"Renal failure in multiple myeloma: reversibility and impact on the prognosis","volume":"65","author":"Knudsen","year":"2000","journal-title":"European Journal of Haematology"},{"key":"10.1016\/j.lrr.2021.100252_bib0023","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/leu.2015.15","article-title":"Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma","volume":"29","author":"Khan","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2021.100252_bib0024","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2019-128041","article-title":"Sex Differences in Multiple Myeloma Biology and Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial","volume":"134","author":"Bird","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2021.100252_bib0025","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/j.clml.2019.09.597","article-title":"VRd versus VCd as induction therapy for newly diagnosed multiple myeloma: A Phase III, randomized study","volume":"19","author":"Kumar","year":"2019","journal-title":"Clinical Lymphoma, Myeloma and Leukemia"},{"key":"10.1016\/j.lrr.2021.100252_bib0026","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.seminhematol.2009.02.005","article-title":"Front-Line Treatment in Younger Patients With Multiple Myeloma","volume":"46","author":"Rajkumar","year":"2009","journal-title":"Semin Hematol"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048921000194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048921000194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:23Z","timestamp":1761959303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048921000194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":26,"alternative-id":["S2213048921000194"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2021.100252","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2021.100252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100252"}}